This website uses cookies to enhance the user experience.
21st logo
||
S

SERB NUF924 580 941

Process industry
Norwegian division of foreign business enterprise
Avenue Louise 480 BE-1050 IXELLES, Belgia

SERB NUF

Operating
Legemiddelproduksjon og farmasøytisk engros.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

Years since formation
6 years
since Feb 19, 2020
Type
Norwegian division of foreign business enterprise
VAT registered
No
Number of employees
0

Financials

Total operating income 2025
2,542,702
NOK
Annual total result 2025
99,469
NOK
Total equity 2025
-3,968,925
NOK
Last update: Aug 6, 2026

Management

Board

NameRoleShares
LB

Luc Bodet

1974

Contact Person-
S
SERB
Information about the Company in the Home Country-
Last update: Apr 13, 2023

Ownership

No available data

Financials

in NOK

Summary

Year2025202420232022
Total operating income
2,542,702
2,448,000
0
0
Annual Total Result
99,469
95,800
-2,782,755
-2,206,820
Total assets
0
0
0
0
Total liabilities
3,968,925
4,068,395
7,055,476
2,206,820
Total equity
-3,968,925
-4,068,395
-7,055,476
-2,206,820

P&L

Year2025202420232022
Total operating income
2,542,702
2,448,000
0
0
Total operating costs
2,415,177
2,325,180
2,782,755
2,206,820
Operating result
127,525
122,820
-2,782,755
-2,206,820
Financial income/costs
0
0
0
0
Profit before tax
127,525
122,820
-2,782,755
-2,206,820
Total tax & extraordinary income/cost
28,056
27,020
0
0
Annual Total Result
99,469
95,800
-2,782,755
-2,206,820

Balance overview

Year2025202420232022
Total fixed assets
0
0
0
0
Total current assets
0
0
0
0
Total assets
0
0
0
0
Short term debt
3,968,925
4,068,395
7,055,476
2,206,820
Long term debt
0
0
0
0
Total liabilities
3,968,925
4,068,395
7,055,476
2,206,820
Contributed capital
0
0
0
0
Retained earnings
-3,968,925
-4,068,395
-7,055,476
-2,206,820
Total equity
-3,968,925
-4,068,395
-7,055,476
-2,206,820
Total equity and liabilities
0
0
0
0

Classification

21st company classification
BETA
Small company
Category
Type of organization
Norwegian division of foreign business enterprise
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations